Targeting strategies for bone diseases: signaling pathways and clinical studies
H Xu, W Wang, X Liu, W Huang, C Zhu, Y Xu… - … and Targeted Therapy, 2023 - nature.com
Since the proposal of Paul Ehrlich's magic bullet concept over 100 years ago, tremendous
advances have occurred in targeted therapy. From the initial selective antibody, antitoxin to …
advances have occurred in targeted therapy. From the initial selective antibody, antitoxin to …
[HTML][HTML] Regulation of Skeletal Development and Maintenance by Runx2 and Sp7
T Komori - International Journal of Molecular Sciences, 2024 - mdpi.com
Runx2 (runt related transcription factor 2) and Sp7 (Sp7 transcription factor 7) are crucial
transcription factors for bone development. The cotranscription factor Cbfb (core binding …
transcription factors for bone development. The cotranscription factor Cbfb (core binding …
An injectable carboxymethyl chitosan hydrogel scaffold formed via coordination bond for antibacterial and osteogenesis in osteomyelitis
T Zhou, H Zhou, F Wang, P Zhang, J Shang… - Carbohydrate Polymers, 2024 - Elsevier
The intricate, hostile, and diverse nature of osteomyelitis (OM) poses a challenge for
complete bacterial eradication and osteogenesis promotion via conventional treatment …
complete bacterial eradication and osteogenesis promotion via conventional treatment …
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
IRF4 International Consortium, O Fornes, A Jia… - Science …, 2023 - science.org
Interferon regulatory factor 4 (IRF4) is a transcription factor (TF) and key regulator of immune
cell development and function. We report a recurrent heterozygous mutation in IRF4, p …
cell development and function. We report a recurrent heterozygous mutation in IRF4, p …
Transcriptional reprogramming by mutated IRF4 in lymphoma
Disease-causing mutations in genes encoding transcription factors (TFs) can affect TF
interactions with their cognate DNA-binding motifs. Whether and how TF mutations impact …
interactions with their cognate DNA-binding motifs. Whether and how TF mutations impact …
SP7: From bone development to skeletal disease
JS Wang, N Tokavanich, MN Wein - Current osteoporosis reports, 2023 - Springer
Abstract Purpose of Review The purpose of this review is to summarize the different roles of
the transcription factor SP7 in regulating bone formation and remodeling, discuss current …
the transcription factor SP7 in regulating bone formation and remodeling, discuss current …
[HTML][HTML] Photothermal switch by gallic acid-calcium grafts synthesized by coordination chemistry for sequential treatment of bone tumor and regeneration
X Hou, L Zhang, Y Chen, Z Liu, X Zhao, B Lu, Y Luo… - Biomaterials, 2025 - Elsevier
The residual bone tumor and defects which is caused by surgical therapy of bone tumor is a
major and important problem in clinicals. And the sequential treatment for irradiating …
major and important problem in clinicals. And the sequential treatment for irradiating …
Update on the genetics of osteogenesis imperfecta
M Jovanovic, JC Marini - Calcified Tissue International, 2024 - Springer
Osteogenesis imperfecta (OI) is a heterogeneous heritable skeletal dysplasia characterized
by bone fragility and deformity, growth deficiency, and other secondary connective tissue …
by bone fragility and deformity, growth deficiency, and other secondary connective tissue …
Sp7 action in the skeleton: Its mode of action, functions, and relevance to skeletal diseases
H Hojo, S Ohba - International Journal of Molecular Sciences, 2022 - mdpi.com
Osteoblast differentiation is a tightly regulated process in which key transcription factors
(TFs) and their target genes constitute gene regulatory networks (GRNs) under the control of …
(TFs) and their target genes constitute gene regulatory networks (GRNs) under the control of …
An injectable carboxymethyl chitosan-based hydrogel with controlled release of BMP-2 for efficient treatment of bone defects
T Zhou, F Wang, K Liu, H Zhou, J Shang - International Journal of …, 2024 - Elsevier
Although biological scaffolds containing bone morphogenetic protein-2 (BMP-2) have been
widely used for osteogenic therapy, achieving stable and controlled release of BMP-2 …
widely used for osteogenic therapy, achieving stable and controlled release of BMP-2 …